Abstract
Multinuclear Pt(II) complexes represent a novel class of antitumor agents. In this work, a dinuclear monofunctional Pt(II) complex {[cis-Pt(NH3)2Cl]2(4,4′-methylenedianiline)}(NO3)2 (1) was synthesized and characterized by 1H NMR, electrospray mass spectrometry, and elemental analysis. The 2D [1H,15N] heteronuclear single quantum coherence NMR spectra of 15N-labeled 1 revealed that the cationic core of this water-soluble complex hardly hydrolyzes in aqueous solution and reacts very slowly with glutathione. Hydrolysis appears not to be an essential step for the formation of Pt–guanosine-5′-monophosphate (5′-GMP) or Pt–DNA adducts because the complex can react readily with 5′-GMP and partially transform B-DNA into its Z form. Such properties are desired to achieve the goal of enhancing cytotoxicity and lowering side effects of Pt(II) complexes. In fact, complex 1 is highly cytotoxic against the murine leukemia (P-388) and the human non-small-cell lung cancer (A-549) cell lines, and it is more cytotoxic than cisplatin at most concentrations tested.
Similar content being viewed by others
References
Abu-Surrah AS, Kettunen M (2006) Curr Med Chem 13:1337–1357
Lippert B (ed) (1999) Cisplatin: chemistry and biochemistry of a leading anticancer drug. Wiley-VCH, Weinheim
Wong E, Giandomenico CM (1999) Chem Rev 99:2451–2466
Kelland LR (2000) Drugs 59:1–8
Dempek W, Voigt W, Grothey A, Hill BT, Schmoll HJ (2000) Anticancer Drugs 11:225–236
Galanski M, Jakupec MA, Keppler BK (2005) Curr Med Chem 12:2075–2094
Wheate NJ, Collins JG (2003) Coord Chem Rev 241:133–145
Qu Y, Rauter H, Soares Fontes AP, Bandarage R, Kelland LR, Farrell N (2000) J Med Chem 43:3189–3192
Komeda S, Kalayda GV, Lutz M, Spek AL, Yamanaka Y, Sato T, Chikuma M, Reedijk J (2003) J Med Chem 46:1210–1219
Kraker AJ, Hoeschele JD, Elliott WL, Showalter HDH, Sercel AD, Farrell NP (1992) J Med Chem 35:4526–4532
Perego P, Caserini C, Gatti L, Carenini N, Romanelli S, Supino R, Colangelo D, Viano I, Leone R, Spinelli S, Pezzoni G, Manzotti C, Farrell N, Zunino F (1999) Mol Pharmacol 55:528–534
Kašpárková J, Nováková O, Vrána O, Farrell N, Brabec V (1999) Biochemistry 38:10997–11005
Kašpárková J, Zehnulova J, Farrell N, Brabec V (2002) J Biol Chem 277:48076–48086
Farrell N (2004) Met Ions Biol Syst 42:251–296
Zehnulová J, Kašparková J, Farrell N, Brabec V (2001) J Biol Chem 276:22191–22199
Brabec V, Kašparková J, Vraná O, Nováková O, Cox JW, Qu Y, Farrell N (1999) Biochemistry 38:6781–6790
Kloster MBG, Hannis JC, Muddiman DC, Farrell N (1999) Biochemistry 38:14731–14737
Farrell N, Qu Y, Bierbach U, Valsecchi M, Menta E (1999) In: Lippert B (ed) Cisplatin: chemistry and biochemistry of a leading anticancer drug. Wiley-VCH, Weinheim, pp 479–498
Farrell N, Appleton TG, Qu Y, Roberts JD, Fontes APS, Skov KA, Wu P, Zou Y (1995) Biochemistry 34:15480–15486
Komeda S, Lutz M, Spek AL, Chikuma M, Reedijk J (2000) Inorg Chem 39:4230–4236
Komeda S, Lutz M, Spek AL, Yamanaka Y, Sato T, Chikuma M, Reedijk J (2002) J Am Chem Soc 124:4738–4746
van Zutphen S, Robillard MS, van der Marel GA, Overkleeft HS, den Dulk H, Brouwer J, Reedijk J (2003) Chem Commun 634–635
Reedijk J (2003) Proc Natl Acad Sci USA 100:3611–3616
Zhao GH, Lin HK, Zhu SR, Sun HW, Chen YT (1998) Anticancer Drug Des 13:769–777
Dhara S (1970) Indian J Chem 8:193
Alley MC, Scudiero DA, Monks A, Hursey ML, Czerwinski MJ, Fine DL, Abbott BJ, Mayo JG, Shoemaker RH, Boyd MR (1988) Cancer Res 48:589–601
Skehan P, Storeng R, Scudiero D, Monks A, McMahon J, Vistica D, Warren JT, Bokesch H, Kenney S, Boyd MR (1990) J Natl Cancer Inst 82:1107–1112
Zhang JY, Wang XY, Tu C, Lin J, Ding J, Lin LP, Wang ZM, He C, Yan CH, You XZ, Guo ZJ (2003) J Med Chem 46:3502–3507
Berners-Price SJ, Ronconi L, Sadler PJ (2006) Prog Nucl Magn Reson Spectrosc 49:65–98
Zhang J, Thomas DS, Davies MS, Berners-Price SJ, Farrell N (2005) J Biol Inorg Chem 10:652–666
Cox JW, Berners SJ, Davies MS, Qu Y, Farrell N (2001) J Am Chem Soc 123:1316–1326
Davies MS, Thomas DS, Hegmans A, Berners-Price SJ, Farrell N (2002) Inorg Chem 41:1101–1109
Hegmans A, Berners-Price SJ, Davies MS, Thomas DS, Humphreys AS, Farrell N (2004) J Am Chem Soc 126:2166–2180
Berners-Price SJ, Frenkiel TA, Frey U, Ranford JD, Sadler PJ (1992) J Chem Soc Chem Commun 789–791
Guo Z, Chen Y, Zang E, Sadler PJ (1997) J Chem Soc Dalton Trans 4107–4111
Barton SJ, Barnham KJ, Habtemariam A, Sue RE, Sadler PJ (1998) Inorg Chim Acta 273:8–13
Davies MS, Cox JW, Berners-Price SJ, Barklage W, Qu Y, Farrell N (2000) Inorg Chem 39:1710–1715
Appleton TG, Hall JR, Ralph SF (1985) Inorg Chem 24:4685–4693
Fichtinger-Schepman AMJ, van der Veer JL, den Hartog JHJ, Lohman PHM, Reedijk J (1985) Biochemistry 24:707–713
Miller SK, Marzilli LG (1985) Inorg Chem 24:2421–2425
Dijt FJ, Canters GW, den Hartog JHJ, Marcelis ATM, Reedijk J (1984) J Am Chem Soc 106:3644–3647
Berners-Price SJ, Frenkiel TA, Ranford JD, Sadler PJ (1992) J Chem Soc Dalton Trans 2137–2139
Wu PK, Kharatishvili M, Qu Y, Farrell N (1996) J Inorg Biochem 63:9–18
Bauer C, Peleg-Shulman T, Gibson D, Wang AHJ (1998) Eur J Biochem 256:253–260
Okada T, El-Mehasseb IM, Kodaka M, Tomohiro T, Okamoto K, Okuno H (2001) J Med Chem 44:4661–4667
Johnson WC (1994) In: Nakanishi K, Berova N, Woody RW (eds) Circular dichroism: principles and applications. VCH, New York, pp 523–540
Kharatishvili M, Mathieson M, Farrell N (1997) Inorg Chim Acta 255:1–6
Zaludová R, Zakovska A, Kaspárková J, Balcarová Z, Kleinwächter V, Vrána O, Farrell N, Brabec V (1997) Eur J Biochem 246:508–517
Johnson NP, Butour JL, Villani G, Wimmer FL, Defais M, Pierson V, Brabec V (1989) Prog Clin Biochem Med 10:1–24
McGregor TD, Balcarová Z, Qu Y, Tran M-C, Zaludová R, Brabec V, Farrell N (1999) J Inorg Biochem 77:43–46
Wei HY, Wang XY, Guo ZJ (2005) In: Pérez JM, Fuertes MA, Alonso C (eds) Metal compounds in cancer chemotherapy. Research Signpost, Kerala, pp 241–267
Eastman A, Richon VM (1986) In: McBrien SCH, Slater TF (eds) Biochemical mechanisms of the platinum antitumor drugs. IRL, Oxford, pp 91–119
Eastman A (1987) Chem Biol Interact 61:241–248
Oehlsen ME, Qu Y, Farrell N (2003) Inorg Chem 42:5498–5506
Holford J, Sharp SY, Murrer BA, Abrams M, Kelland LR (1998) Br J Cancer 77:366–373
Oehlsen ME, Hegmans A, Qu Y, Farrell N (2005) Inorg Chem 44:3004–3006
Oehlsen ME, Hegmans A, Qu Y, Farrell N (2005) J Biol Inorg Chem 10:433–442
Acknowledgements
Financial support from the National Natural Science Foundation of China (nos. 20231010, 20228102, 30370351) and the Natural Science Foundation of Jiangsu Province (no. BK 2005209) is gratefully acknowledged.
Author information
Authors and Affiliations
Corresponding authors
Electronic supplementary material
Below is the link to the electronic supplementary material.
Rights and permissions
About this article
Cite this article
Fan, D., Yang, X., Wang, X. et al. A dinuclear monofunctional platinum(II) complex with an aromatic linker shows low reactivity towards glutathione but high DNA binding ability and antitumor activity. J Biol Inorg Chem 12, 655–665 (2007). https://doi.org/10.1007/s00775-007-0214-1
Received:
Accepted:
Published:
Issue Date:
DOI: https://doi.org/10.1007/s00775-007-0214-1